EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Blockade of mTORC1 via Rapamycin Suppresses 27-Hydroxycholestrol-Induced Inflammatory Responses

Nakyung Kang, Jaesung Kim, Munju Kwon iD, Yonghae Son iD, Seong-Kug Eo, Ninib Baryawno, Byoung Soo Kim iD, Sik Yoon iD, Sae-Ock Oh, Dongjun Lee iD, Koanhoi Kim

International Journal of Molecular Sciences · 2024

DOI: 10.3390/ijms251910381 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2024. Verfasst von Nakyung Kang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, School of Medicine, Pusan National University, Yangsan 50612, Republic of Korea. Hauptthemen laut MEDLINE: Mechanistic Target of Rapamycin Complex 1, Sirolimus, Inflammation, Signal Transduction. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Research Foundation of Korea, Korean Cell-Based Artificial Blood Project funded by the Korean government, Korean government (Ministry of Science and ICT, Ministry of Trade, Industry, and Energy, Ministry of Health and Welfare, and Ministry of Food and Drug Safety).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Atherosclerosis is characterized by the deposition and accumulation of extracellular cholesterol and inflammatory cells in the arterial blood vessel walls, and 27-hydroxycholesterol (27OHChol) is the most abundant cholesterol metabolite. 27OHChol is an oxysterol that induces immune responses, including immune cell activation and chemokine secretion, although the underlying mechanisms are not fully understood. In this study, we investigated the roles of the mechanistic target of rapamycin (mTOR) in 27HChol-induced inflammation using rapamycin. Treating monocytic cells with rapamycin effectively reduced the expression of CCL2 and CD14, which was involved with the increased immune response by 27OHChol. Rapamycin also suppressed the phosphorylation of S6 and 4EBP1, which are downstream of mTORC1. Additionally, it also alleviates the increase in differentiation markers into macrophage. These results suggest that 27OHChol induces inflammation by activating the mTORC1 signaling pathway, and rapamycin may be useful for the treatment of atherosclerosis-related inflammation involving 27OHchol.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mechanistic Target of Rapamycin Complex 1SirolimusInflammationSignal TransductionHumansHydroxycholesterolsChemokine CCL2MacrophagesAtherosclerosisPhosphorylationLipopolysaccharide ReceptorsTHP-1 CellsMonocytes

Stichwörter der Autor:innen

27-hydroxycholesterolinflammationmTORmonocytic cellsrapamycin

Substanzen

Mechanistic Target of Rapamycin Complex 1Sirolimus27-hydroxycholesterolHydroxycholesterolsChemokine CCL2Lipopolysaccharide ReceptorsCCL2 protein, human

Autor:innen und Institutionen

  • Department of Pharmacology, School of Medicine, Pusan National University, Yangsan 50612, Republic of Korea.
  • Department of Convergence Medicine, School of Medicine, Pusan National University, Yangsan 50612, Republic of Korea.
  • College of Veterinary Medicine and Bio-Safety Research Institute, Jeonbuk National University, Iksan 54596, Republic of Korea.
  • Childhood Cancer Research Unit, Department of Women's and Children's Health, Karolinska Institute, 17177 Stockholm, Sweden.
  • School of Biomedical Convergence Engineering, Pusan National University, Yangsan 50612, Republic of Korea.
  • Department of Anatomy, School of Medicine, Pusan National University, Yangsan 50612, Republic of Korea.

ORCID-Profile: Munju Kwon, Yonghae Son, Byoung Soo Kim, Sik Yoon, Dongjun Lee

Förderung

  • National Research Foundation of Korea
  • Korean Cell-Based Artificial Blood Project funded by the Korean government
  • Korean government (Ministry of Science and ICT, Ministry of Trade, Industry, and Energy, Ministry of Health and Welfare, and Ministry of Food and Drug Safety)
  • Ministry of Education and Ministry of Health and Welfare

Zitieren

APA

Kang, N., Kim, J., Kwon, M., Son, Y., Eo, S. K., Baryawno, N., Kim, B. S., Yoon, S., Oh, S. O., Lee, D., & Kim, K. (2024). Blockade of mTORC1 via Rapamycin Suppresses 27-Hydroxycholestrol-Induced Inflammatory Responses. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms251910381

Vancouver

Kang N, Kim J, Kwon M, Son Y, Eo SK, Baryawno N, et al. Blockade of mTORC1 via Rapamycin Suppresses 27-Hydroxycholestrol-Induced Inflammatory Responses. International Journal of Molecular Sciences. 2024. doi:10.3390/ijms251910381

BibTeX
@article{Kang2024,
  author = {Kang, Nakyung and Kim, Jaesung and Kwon, Munju and Son, Yonghae and Eo, Seong-Kug and Baryawno, Ninib and Kim, Byoung Soo and Yoon, Sik and Oh, Sae-Ock and Lee, Dongjun and Kim, Koanhoi},
  title = {Blockade of mTORC1 via Rapamycin Suppresses 27-Hydroxycholestrol-Induced Inflammatory Responses},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  doi = {10.3390/ijms251910381}
}
Kostenlos starten →